Gut Microbiome and Pulmonary Arterial Hypertension – A Novel and Evolving Paradigm
Physiological Research · 29.11.2024 · S477-S485
DOI: 10.33549/physiolres.935430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Research, online erschienen am 22.11.2024. Verfasst von T Thenappan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Pulmonary arterial hypertension is characterized by perivascular and systemic inflammation. The gut microbiome influences the host immune system. Here we review the emerging preclinical and clinical evidence that strongly suggests that alterations in the gut microbiome may either initiate or facilitate progression of established pulmonary arterial hypertension by modifying the systemic immune responses. We also briefly review the relationship between the gut microbiome and preeclampsia, a vascular disease also characterized by inflammation.
Zitieren
APA
Thenappan, T., & Weir, E. (2024). Gut Microbiome and Pulmonary Arterial Hypertension – A Novel and Evolving Paradigm. Physiological Research, S477-S485. https://doi.org/10.33549/physiolres.935430
Vancouver
Thenappan T, Weir E. Gut Microbiome and Pulmonary Arterial Hypertension – A Novel and Evolving Paradigm. Physiological Research. 2024:S477-S485. doi:10.33549/physiolres.935430
BibTeX
@article{Thenappan2024,
author = {Thenappan, T and Weir, EK},
title = {Gut Microbiome and Pulmonary Arterial Hypertension – A Novel and Evolving Paradigm},
journal = {Physiological Research},
year = {2024},
pages = {S477--S485},
doi = {10.33549/physiolres.935430}
}
EUVIMED